These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 2797067)

  • 1. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes.
    Cowie CC; Port FK; Wolfe RA; Savage PJ; Moll PP; Hawthorne VM
    N Engl J Med; 1989 Oct; 321(16):1074-9. PubMed ID: 2797067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in survival between black and white patients with diabetic end-stage renal disease.
    Cowie CC; Port FK; Rust KF; Harris MI
    Diabetes Care; 1994 Jul; 17(7):681-7. PubMed ID: 7924777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial differences in the incidence of end-stage renal disease.
    Tell GS; Hylander B; Craven TE; Burkart J
    Ethn Health; 1996 Mar; 1(1):21-31. PubMed ID: 9395545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NIDDM is the major cause of diabetic end-stage renal disease. More evidence from a tri-ethnic community.
    Pugh JA; Medina RA; Cornell JC; Basu S
    Diabetes; 1995 Dec; 44(12):1375-80. PubMed ID: 7589841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors.
    Brancati FL; Whittle JC; Whelton PK; Seidler AJ; Klag MJ
    JAMA; 1992 Dec; 268(21):3079-84. PubMed ID: 1433738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. End-stage renal disease attributable to diabetes mellitus.
    Perneger TV; Brancati FL; Whelton PK; Klag MJ
    Ann Intern Med; 1994 Dec; 121(12):912-8. PubMed ID: 7978716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial differences in the incidence of end-stage renal disease in types I and II diabetes mellitus.
    Stephens GW; Gillaspy JA; Clyne D; Mejia A; Pollak VE
    Am J Kidney Dis; 1990 Jun; 15(6):562-7. PubMed ID: 2368696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excess incidence of treatment of end-stage renal disease in Mexican Americans.
    Pugh JA; Stern MP; Haffner SM; Eifler CW; Zapata M
    Am J Epidemiol; 1988 Jan; 127(1):135-44. PubMed ID: 3276155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiologic analysis of diabetic patients on chronic dialysis.
    Sunagawa H; Iseki K; Nishime K; Uehara H; Toma S; Kinjo K; Fukiyama K
    Nephron; 1996; 74(2):361-6. PubMed ID: 8893156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninsulin-dependent diabetes mellitus in black and white Americans.
    Harris MI
    Diabetes Metab Rev; 1990 Mar; 6(2):71-90. PubMed ID: 2198151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of youth-onset noninsulin-dependent diabetes mellitus and insulin-dependent diabetes mellitus at diagnosis.
    Scott CR; Smith JM; Cradock MM; Pihoker C
    Pediatrics; 1997 Jul; 100(1):84-91. PubMed ID: 9200365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidences, treatments, outcomes, and sex effect on survival in patients with end-stage renal disease by diabetes status in Australia and New Zealand (1991 2005).
    Villar E; Chang SH; McDonald SP
    Diabetes Care; 2007 Dec; 30(12):3070-6. PubMed ID: 17848610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The low birth weight hypothesis as a plausible explanation for the black/white differences in hypertension, non-insulin-dependent diabetes, and end-stage renal disease.
    Lopes AA; Port FK
    Am J Kidney Dis; 1995 Feb; 25(2):350-6. PubMed ID: 7847366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic renal disease in blacks--inevitable or preventable?
    Rostand SG
    N Engl J Med; 1989 Oct; 321(16):1121-2. PubMed ID: 2797070
    [No Abstract]   [Full Text] [Related]  

  • 15. Diabetic renal disease: racial and ethnic differences from an epidemiologic perspective.
    Cowie CC
    Transplant Proc; 1993 Aug; 25(4):2426-30. PubMed ID: 8356621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-insulin-dependent diabetes and renal replacement therapy.
    Grenfell A; Bewick M; Parsons V; Snowden S; Taube D; Watkins PJ
    Diabet Med; 1988 Mar; 5(2):172-6. PubMed ID: 2964985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes-related end-stage renal disease in Missouri: trends and variations by age and race.
    Urriola-Acheson A; Sharp DJ; Kruse KH; Austin DE; Weaver A; Brownson RC
    Mo Med; 1994 Jun; 91(6):287-90. PubMed ID: 8052218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revisiting racial differences in ESRD due to ADPKD in the United States.
    Murphy EL; Dai F; Blount KL; Droher ML; Liberti L; Crews DC; Dahl NK
    BMC Nephrol; 2019 Feb; 20(1):55. PubMed ID: 30764782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between chronic renal failure and renal cell carcinoma may differ between black and white Americans.
    Hofmann JN; Schwartz K; Chow WH; Ruterbusch JJ; Shuch BM; Karami S; Rothman N; Wacholder S; Graubard BI; Colt JS; Purdue MP
    Cancer Causes Control; 2013 Jan; 24(1):167-74. PubMed ID: 23179659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained Lower Incidence of Diabetes-Related End-Stage Kidney Disease Among American Indians and Alaska Natives, Blacks, and Hispanics in the U.S., 2000-2016.
    Burrows NR; Zhang Y; Hora I; Pavkov ME; Sheff K; Imperatore G; Bullock AK; Albright AL
    Diabetes Care; 2020 Sep; 43(9):2090-2097. PubMed ID: 32616609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.